-
Viewpoint: If It Ain’t Broke, Don’t Fix It
In October of 2015, Universities Allied for Essential Medicines (UAEM) released an open letter with the title Make Medicines for People Not for Profit. The letter – now signed by a wide range of academics and researchers, including Nobel Prize-winning economist Joseph Stiglitz – issues a call for a “global research and development (R&D) agreement to ensure access to affordable vaccines, medicines and life-saving technologies for all.”
- Categories
- Health Care
- Tags
- vaccines
-
Austrian Biotech Plans Zika Vaccine Clinical Trials in 12 Months
An Austrian biotech company working with the Institut Pasteur said on Tuesday it planned to start clinical trials with an experimental Zika vaccine in the next 12 months, marking a further acceleration of research in the field.
- Categories
- Health Care
- Region
- Europe & Eurasia
-
Swine Flu Adds to Brazil’s Zika Worries
Brazil, which will host the Olympics beginning Aug. 5, was already beset by economic problems, a political crisis and the Zika outbreak. Now it's experiencing its worst swine flu outbreak since 2009. Dr. Melvin Sanicas, a program officer at the Bill & Melinda Gates Foundation, wonders if this will be the crisis that forces a change to the Olympic schedule.
- Categories
- Health Care
-
Scientists announce important Zika milestone: First vaccine ready for human trials
Pennsylvania vaccine maker Inovio Pharmaceuticals and South Korea’s GeneOne Life Sciences said Monday that they had received approval from U.S. regulators to start testing a DNA vaccine, known as GLS-5700, on humans.
- Categories
- Health Care
-
‘Disease outbreak guarantees’—A proposed mechanism for enhancing public health capacity
The possible path to offering disease outbreak guarantees is an idea being posed by two global health researchers who suggest that a mechanism for establishing such an instrument could be tied to public health investments.
- Categories
- Health Care
-
With Another Pandemic Looming, Let’s Change Perspective
We cannot prevent the emergence of new viruses, according to Dr. Melvin Sanicas, a Global Health Fellow and program officer at the Bill & Melinda Gates Foundation, but we can take measures to prevent small epidemics from becoming big ones, including investing in infrastructures for preparedness.
- Categories
- Health Care
-
Why the Vaccination Supply Chain Needs Reform
I recently returned from a week in Mozambique with a goal of learning about new immunization supply chain models and observing their impact. I also wanted to better understand opportunities and constraints for taking this work to scale -- in Mozambique and across other Gavi-eligible countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- supply chains, vaccines
-
Behind the World’s Top Drugmakers’ Approach to Zika Vaccine
What if a drugmaker spent billions of dollars to create a vaccine -- only to find out humans developed natural resistance to the disease before its product is ready?
- Categories
- Health Care
- Region
- Latin America
- Tags
- vaccines
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.